Key result
Single-session combined TAVR, angioplasty, and stenting achieves immediate hemodynamic and symptom relief.
Why the study?
The coexistence of aortic valve stenosis and regurgitation with native coarctation is a rare and complex condition in adults, especially those with significant surgical risks, complicating management.
Does a single-session transcatheter approach improve hemodynamics and clinical symptoms in a high-risk patient with combined aortic valve disease and aortic coarctation?
Case Report (n=1)
No
Does a single-session transcatheter approach improve hemodynamics and clinical symptoms in a high-risk patient with combined aortic valve disease and aortic coarctation?
A single-session combined transcatheter strategy (balloon angioplasty, TAVR, and stent implantation) offers a safe, effective, and minimally invasive alternative for high-risk adults presenting with coexisting severe aortic valve disease and aortic coarctation.
May inform management of rare combined aortic lesions in prohibitive-risk patients; leaves open durability, generalizability, and need for prospective data.
BACKGROUND: The coexistence of aortic valve stenosis and regurgitation with native coarctation is a rare and complex condition in adults, especially those with significant surgical risks, complicating management. CASE SUMMARY: A 60-year-old male with poorly controlled hypertension, chronic kidney disease, and atrial fibrillation presented with progressive dyspnea and chest tightness. Echocardiography revealed a bicuspid aortic valve with moderate stenosis and regurgitation, reduced ejection fraction, and left ventricular dilation. Computed tomography showed near-occlusive coarctation of the descending aorta. Given high surgical risk, conventional surgery was deemed unfeasible. DISCUSSION: A single-session transcatheter "one-stop" approach, combining balloon angioplasty, aortic valve replacement, and stent implantation, was performed, resulting in immediate hemodynamic improvement. TAKE-HOME MESSAGE: A unified, single-session transcatheter strategy offers a safe and effective alternative for high-risk patients with aortic valve disease and coarctation.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) conducted a case report in Severe aortic valve disease and aortic coarctation (n=1). Single-session transcatheter approach (balloon angioplasty, TAVR, and CP stent implantation) was evaluated on Hemodynamic improvement and symptom resolution. A unified, single-session transcatheter strategy combining balloon angioplasty, aortic valve replacement, and stent implantation successfully achieved immediate hemodynamic improvement and symptom resolution in a high-risk patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: